Molecular Partners AG MOL.N-CH:Swiss Exchange

*Data is delayed | Exchange | CHF
Last | 02/08/23 CET
6.12UNCH (UNCH)
52 week range
5.27 - 25.05
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close6.12
  • 52 Week High25.05
  • 52 Week High Date02/07/22
  • 52 Week Low5.27
  • 52 Week Low Date08/29/22

Key Stats

  • Market Cap212.95M
  • Shares Out32.51M
  • 10 Day Average Volume43,415
  • Dividend-
  • Dividend Yield-
  • Beta-0.17
  • YTD % Change-0.65

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close6.12
  • 52 Week High25.05
  • 52 Week High Date02/07/22
  • 52 Week Low5.27
  • 52 Week Low Date08/29/22
  • Market Cap212.95M
  • Shares Out32.51M
  • 10 Day Average Volume43,415
  • Dividend-
  • Dividend Yield-
  • Beta-0.17
  • YTD % Change-0.65

RATIOS/PROFITABILITY

  • EPS (TTM)3.52
  • P/E (TTM)1.74
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Molecular Partners AG

 

Content From Our Affiliates

Profile

MORE
Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical...
William Burns
Non-Executive Independent Chairman of the Board
Patrick Amstutz Ph.D.
Chief Executive Officer, Executive Director, Member of the Management Board
Michael Stumpp Ph.D.
Chief Operating Officer, Member of the Management Board
Andreas Emmenegger
Chief Financial Officer, Member of the Management Board
Address
Wagistrasse 14
Schlieren
8952
Switzerland